In-stent Restenosis
43
5
10
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 43 trials
100.0%
+13.5% vs benchmark
26%
11 trials in Phase 3/4
38%
5 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (43)
Functional Milk Supplementation to Reduce In-Stent Restenosis in STEMI Patients (SMASOEA Trial)
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort
VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
Target Vessel Failure After Laser Assisted Percutaneous Angioplasty Versus Balloon-based Treatment for Drug Eluting In-stent Restenosis
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
CVT-ISR First in Human Trial for Coronary In-Stent Restenosis
Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)
Pilot Study of the α Prototype NIMBLE System: Feasibility, Safety, and Initial Performance in Non-Invasive Detection of Coronary In-Stent Restenosis
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon
Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention
Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)
Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study
Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT
Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment
CT-FFR-guided Strategy for In-stent Restenosis